Literature DB >> 18342309

Pallidal neuronal discharge in Huntington's disease: support for selective loss of striatal cells originating the indirect pathway.

Philip A Starr1, Gail A Kang, Susan Heath, Shoichi Shimamoto, Robert S Turner.   

Abstract

Chorea is the predominant motor manifestation in the early symptomatic phase of adult onset Huntington's disease (HD). Pathologically, this stage is marked by differential loss of striatal neurons contributing to the indirect pathway. This pattern of neuronal loss predicts decreased neuronal firing rates in GPi and increased firing rates in GPe, the opposite of the changes in firing rate known to occur in Parkinson's disease (PD). We present single-unit discharge characteristics (33 neurons) observed in an awake patient with HD (41 CAG repeats) undergoing microelectrode guided surgery for pallidal deep brain stimulation. Pallidal single-unit activity at "rest" and during voluntary movement was discriminated off line by principal component analysis and evaluated with respect to discharge rate, bursting, and oscillatory activity in the 0-200 Hz range. 24 GPi and 9 GPe units were studied, and compared with 132 GPi and 50 GPe units from 14 patients with PD. The mean (+/-SEM) spontaneous discharge rate for HD was 58+/-4 for GPi and 73+/-5 for GPe. This contrasted with discharge rates in PD of 95+/-2 for GPi and 57+/-3 for GPe. HD GPi units showed more bursting than PD GPi units but much less oscillatory activity in the 2-35 Hz frequency range at rest. These findings are consistent with selective early loss of striatal cells originating the indirect pathway.

Entities:  

Mesh:

Year:  2008        PMID: 18342309      PMCID: PMC3673313          DOI: 10.1016/j.expneurol.2008.01.023

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  36 in total

1.  Burst and oscillation as disparate neuronal properties.

Authors:  Y Kaneoke; J L Vitek
Journal:  J Neurosci Methods       Date:  1996-10       Impact factor: 2.390

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease.

Authors:  J L Vitek; R A Bakay; T Hashimoto; Y Kaneoke; K Mewes; J Y Zhang; D Rye; P Starr; M Baron; R Turner; M R DeLong
Journal:  J Neurosurg       Date:  1998-06       Impact factor: 5.115

4.  Characteristics and somatotopic organization of kinesthetic cells in the globus pallidus of patients with Parkinson's disease.

Authors:  J M Taha; J Favre; T K Baumann; K J Burchiel
Journal:  J Neurosurg       Date:  1996-12       Impact factor: 5.115

5.  Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.

Authors:  G V Rebec; S K Conroy; S J Barton
Journal:  Neuroscience       Date:  2005-10-28       Impact factor: 3.590

6.  Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus.

Authors:  J L Vitek; V Chockkan; J Y Zhang; Y Kaneoke; M Evatt; M R DeLong; S Triche; K Mewes; T Hashimoto; R A Bakay
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

7.  Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates.

Authors:  T Wichmann; H Bergman; P A Starr; T Subramanian; R L Watts; M R DeLong
Journal:  Exp Brain Res       Date:  1999-04       Impact factor: 1.972

8.  Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.

Authors:  Menekse Alpay; Walter J Koroshetz
Journal:  Psychosomatics       Date:  2006 Jan-Feb       Impact factor: 2.386

9.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

10.  Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.

Authors:  E Sapp; P Ge; H Aizawa; E Bird; J Penney; A B Young; J P Vonsattel; M DiFiglia
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

View more
  28 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists.

Authors:  Yoko Tanimura; Sasha Vaziri; Mark H Lewis
Journal:  Behav Brain Res       Date:  2010-02-21       Impact factor: 3.332

Review 3.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

4.  Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

Authors:  Benjamin Pasquereau; Robert S Turner
Journal:  Cereb Cortex       Date:  2010-11-02       Impact factor: 5.357

Review 5.  [Deep brain stimulation for hyperkinetic movement disorders].

Authors:  M M Reich; J Volkmann
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 6.  Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation.

Authors:  Claudio Da Cunha; Suelen L Boschen; Alexander Gómez-A; Erika K Ross; William S J Gibson; Hoon-Ki Min; Kendall H Lee; Charles D Blaha
Journal:  Neurosci Biobehav Rev       Date:  2015-02-12       Impact factor: 8.989

7.  Intrinsic dynamics and synaptic inputs control the activity patterns of subthalamic nucleus neurons in health and in Parkinson's disease.

Authors:  C J Wilson; M D Bevan
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

Review 8.  Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects.

Authors:  Jonathan E Rubin; Cameron C McIntyre; Robert S Turner; Thomas Wichmann
Journal:  Eur J Neurosci       Date:  2012-07       Impact factor: 3.386

Review 9.  Reassessing models of basal ganglia function and dysfunction.

Authors:  Alexandra B Nelson; Anatol C Kreitzer
Journal:  Annu Rev Neurosci       Date:  2014       Impact factor: 12.449

10.  Reduction of repetitive behavior by co-administration of adenosine receptor agonists in C58 mice.

Authors:  Mark H Lewis; Hemangi Rajpal; Amber M Muehlmann
Journal:  Pharmacol Biochem Behav       Date:  2019-05-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.